{"filing":{"accession_number":"0001193125-26-318853","cik":"0000730272","ticker":"RGEN","company_name":"REPLIGEN CORP","form":"8-K","filing_date":"2026-07-28","report_date":"2026-07-28","primary_document":"rgen-20260728.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526318853/rgen-20260728.htm"},"events":[{"id":20900,"run_id":18820,"accession_number":"0001193125-26-318853","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Repligen Corporation disclosed its second quarter 2026 financial results on July 28, 2026, including Q2 revenue of $204 million (12% YoY increase), GAAP operating income of $14 million, and adjusted EPS of $0.54. The company also raised full-year 2026 guidance for organic revenue growth to 10.5%-13.5% and adjusted EPS to $2.03-$2.09. This is a standard quarterly earnings release filed under Item 2.02 with the full press release attached as Exhibit 99.1.","company_name":"REPLIGEN CORP","ticker":"RGEN","filing_date":"2026-07-28","form":"8-K","submitted_at":null,"items":[{"id":20404,"accession_number":"0001193125-26-318853","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Repligen Corporation disclosed its second quarter 2026 financial results on July 28, 2026, including Q2 revenue of $204 million (12% YoY increase), GAAP operating income of $14 million, and adjusted EPS of $0.54. The company also raised full-year 2026 guidance for organic revenue growth to 10.5%-13.5% and adjusted EPS to $2.03-$2.09. This is a standard quarterly earnings release filed under Item 2.02 with the full press release attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T11:14:40.157253+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20404,"accession_number":"0001193125-26-318853","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Repligen Corporation disclosed its second quarter 2026 financial results on July 28, 2026, including Q2 revenue of $204 million (12% YoY increase), GAAP operating income of $14 million, and adjusted EPS of $0.54. The company also raised full-year 2026 guidance for organic revenue growth to 10.5%-13.5% and adjusted EPS to $2.03-$2.09. This is a standard quarterly earnings release filed under Item 2.02 with the full press release attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T11:14:40.157253+00:00","company_name":"REPLIGEN CORP","ticker":"RGEN","filing_date":"2026-07-28"}]}